Friday, April 25, 2014 | 8:00 AM - 5:30 PM
Keynote Speakers: Jane M. Carlton (New York University), Rick M. Fairhurst (National Institute of Allergy and Infectious Disease, NIH), Terrie E. Taylor (Michigan State University)
Speakers: Myles Akabas (Albert Einstein College of Medicine), Purnima Bhanot (UMDNJ - New Jersey Medical School), Liwang Cui (Pennsylvania State University), Mahalia S. Desruisseaux (Albert Einstein College of Medicine), Miriam K. Laufer (University of Maryland School of Medicine), Laura Kirkman (Weill Cornell Medical College), Marcus Lee (Columbia University), Alexander Ploss (Princeton University), Photini Sinnis (Johns Hopkins University)
Despite a 25% reduction in global malaria mortality since 2000, around half the world's population is at risk. Join us on World Malaria Day to examine breakthroughs in pathophysiology, pre-erythrocytic and liver stage biology, and drug development.
Monday, May 5, 2014 | 7:30 AM - 3:00 PM
Speakers: Fareed Abdullah (South African National AIDS Council, Pretoria, South Africa), Frederick Altice (Yale School of Medicine, New Haven, CT, USA), Joe Amon (Human Rights Watch, New York, NY, USA), Chasity Andrews (Aaron Diamond AIDS Research Center, New York, NY, USA), Chris Beyrer (Johns Hopkins Bloomberg School of Public Health, Baltimore, PA, USA), Frances Cowan (Centre for Sexual Health and HIV/AIDS Research Zimbabwe, Zimbabwe), Anna-Louise Crago (University of Toronto, Canada), Steven Deeks (University of California - San Francisco, CA, USA), Jerome Kim (Walter Reed Army Institute of Research, Bethesda, MD, USA), Luiz Loures (UNAIDS, Geneva, Switzerland), Kristen Marks (Weill Cornell Medical College, New York, NY, USA), Daniel Raymond (Harm Reduction Coalition, New York, NY, USA), Pavlo Smyrnov (International HIV/AIDS Alliance in Ukraine, Ukraine)
The UNAIDS' vision of zero new HIV infections, zero AIDS-related deaths and zero discrimination provides a clear path for HIV research and policy. This symposium convenes clinicians, scientists, activists and policy-makers with the shared goal of improving outcomes for HIV in key vulnerable populations.
Tuesday, May 20, 2014 | 8:00 AM - 5:00 PM
Speakers: Timothy Charlebois (Pfizer), David King (AnaptysBio Inc.), William M. Pardridge (Brain Research Institute, UCLA), Steven J. Projan (MedImmune), Sachdev Siddhu (University of Toronto), E. Sally Ward (UT Southwestern), Patrick C. Wilson (The University of Chicago), K. Dane Wittrup (Massachusetts Institute of Technology)
New technologies are pivotal in developing next-generation biologics. This symposium highlights novel technologies in the discovery of new biologics, elucidating in vivo mechanisms of therapeutic proteins, and manufacturing and delivery processes.
Tuesday, June 3, 2014 | 9:30 AM - 2:30 PM
Keynote Speaker: Michael Marletta (The Scripps Research Institute)
The Chemical Biology Discussion Group brings together chemists and biologists interested in discussing the latest breakthroughs. The year-end meeting features keynote speaker Michael Marletta of the Scripps Research Institute and a poster session.
Thursday, June 26, 2014 | 7:45 AM - 5:45 PM
Speakers: Douglas Arnold (McGill University), Diego Cadavid (Biogen Idec), Patrizia Casaccia (Mount Sinai School of Medicine), Jonah Chan (University of California, San Francisco), Andrew Eisen (Acorda Therapeutics), Charles ffrench-Constant (MRC Centre for Regenerative Medicine, University of Edinburgh), Vittorio Gallo (Children's National Medical Center and George Washington University), Steven Goldman (University of Rochester Medical Center), Luke Lairson (The Scripps Research Institute), Catherine Lubetzki (Pierre and Marie Curie University), Wendy B. Macklin (University of Colorado School of Medicine), Daniel Pelletier (Yale School of Medicine), David Rowitch (University of California, San Francisco), Bruno Stankoff (Pierre and Marie Curie University)
This translational conference will highlight biological and clinical findings in myelin development, new techniques for brain imaging and for screening molecular targets, and novel therapeutics that promote remyelination.
Thursday, April 10, 2014 | 8:30 AM - 4:30 PM
Speakers: Robert Balaban (National Heart, Lung, and Blood Institute, NIH), Robert Bao (Massachusetts General Hospital), Salvatore DiMauro (Columbia University Medical Center), Steven Gross (Weill Cornell Medical College), Costas A. Lyssiotis (Weill Cornell Medical College), Jared Rutter (University of Utah School of Medicine), Hazel H. Szeto (Weill Cornell Medical College), Benjamin P. Tu (UT Southwestern Medical Center)
Damage to mitochondria, which are critical in metabolism, underlies a wide range of human diseases, making them an important therapeutic target. Researchers aim to characterize and cure diseases arising from aberrant mitochondrial metabolism.
Tuesday, April 8, 2014 | 8:30 AM - 4:30 PM
Speakers: Dan V. Iosifescu (Icahn School of Medicine at Mount Sinai), Daniel C. Javitt (Columbia University and Nathan Kline Institute), John H. Krystal (Yale University), Andrew F. Leuchter (University of California, Los Angeles), Gregory Light (University of California, San Diego), Siva Digavalli (Bristol-Myers Squibb), Eva Redei (Northwestern University), Steven J. Siegel (University of Pennsylvania)
Recent breakthrough insights from clinical studies are illuminating the neurobiology of psychiatric disorders. This symposium explores differences in sensory processing, imaging, and other biomarkers that may translate findings to animal models.
Tuesday, March 25, 2014 | 12:00 PM - 4:00 PM
Speakers: Rolf Brekken (UT Southwestern), Jessica S. Donington (NYU Langone Medical Center), Balazs Halmos (Columbia University Medical Center), Roy S. Herbst (Yale School of Medicine), Suresh S. Ramalingam (Emory University)
Recent treatment advances may improve lung cancer patient survival rates, as understanding genetic heterogeneity can improve trial patient selection. Hear updates on common mutations, intraoperative chemotherapy, and insights from clinical trials.
Monday, March 24, 2014 | 8:00 AM - 5:00 PM
Speakers: David Alland (Rutgers New Jersey Medical School), Stephanie Boisson-Dupuis (The Rockefeller University), Andrea M. Cooper (Trudeau Institute), Jerrold J. Ellner (Boston Medical Center), Daniel E. Everitt (TB Alliance), Michael S. Glickman (Memorial Sloan-Kettering Cancer Center), Kathleen A. McDonough (Wadsworth Center ), Steven A. Porcelli (Albert Einstein College of Medicine), Kyu Rhee (Weill Cornell Medical College), G. Marcela Rodriguez (Rutgers New Jersey Medical School), Padmini Salgame (Rutgers New Jersey Medical School), Marie Samanovic (NYU Langone Medical Center), Jessica C. Seeliger (Stony Brook University)
TB is a curable infection that should be a disease of the past, yet a third of the world's population remains affected. Join us on World TB Day to explore scientific insights towards novel diagnostics, therapeutics and vaccine-related tools.
Organizers: Raj Bawa (Bawa Biotech LLC; Rensselaer Polytechnic Institute), Scott E. McNeil
(Nanotechnology Characterization Laboratory – Frederick National Laboratory for Cancer Research), Stefan Mühlebach (Vifor Pharma Ltd.; University of Basel, Switzerland), Melanie Brickman Stynes (The New York Academy of Sciences), and Melinda Miller (The New York Academy of Sciences)
Keynote Speaker: Sally Tinkle (Science and Technology Policy Institute, IDA)
This eBriefing explores regulatory challenges in the nascent field of nanomedicines.
Organizers: Mandë Holford (Hunter College, CUNY; American Museum of Natural History), Steven Gross (Weill Cornell Medical College), and Jennifer Henry (The New York Academy of Sciences)
Keynote Speaker: Baldomero M. Olivera (University of Utah)
Venomous animals, including spiders, snakes, scorpions, sea snails, leeches, and others, produce millions of bioactive compounds, offering enormous potential for venom-based drug discovery.
Organizers: John E. Hambor (Boehringer Ingelheim Pharmaceuticals) and Jennifer Henry (The New York Academy of Sciences)
Dendritic cells offer promise in the development of cancer vaccines.
Organizers: Katalin Kauser (Bayer HealthCare), Scott MacDonnell (Boehringer Ingelheim Pharmaceuticals), Silvia Pomposiello (F. Hoffmann-La Roche), Carolyn Foster, and Jennifer Henry (The New York Academy of Sciences)
Fibrosis is common in chronic organ injury, leading to progressive life-threatening outcomes. This eBriefing reviews the link between fibrosis and disease and explores how to use biomarkers and imaging to translate laboratory results into clinical success.
Delve into the world of prebiotic and probiotic science. We talk to three people in the field and learn why keeping the good microbes in our bodies happy means a lot for health.
December 18, 2009
We sit down with science photographer Felice Frankel and nanotechnology pioneer and Harvard chemist George Whitesides to hear about their new book on nanoscience, No Small Matter.
Translational Medicine Initiative
The Translational Medicine Initiative represents a three-year partnership between the New York Academy of Sciences and the Josiah Macy, Jr. Foundation to support the translation of basic science research into clinical applications.
Learn more at www.nyas.org/TransMed.